ERBB2 and non-small cell lung carcinoma: Based on the previous analysis, the effect of T-DM1 and trastuzumab on cell viability was focused on NSCLC cell lines expressing different cell surface levels of HER-2: Calu-3 (very high), H3255 (high) and Calu-6 (low).